1. Home
  2. CCLD vs ICCC Comparison

CCLD vs ICCC Comparison

Compare CCLD & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

N/A

Current Price

$2.47

Market Cap

98.6M

Sector

Technology

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$9.91

Market Cap

93.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCLD
ICCC
Founded
1999
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.6M
93.1M
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
CCLD
ICCC
Price
$2.47
$9.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
463.1K
27.5K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
135.71
53.85
EPS
N/A
0.41
Revenue
$120,499,000.00
$26,493,169.00
Revenue This Year
$11.49
N/A
Revenue Next Year
$7.95
N/A
P/E Ratio
N/A
$24.24
Revenue Growth
8.72
51.64
52 Week Low
$2.03
$4.52
52 Week High
$3.98
$12.10

Technical Indicators

Market Signals
Indicator
CCLD
ICCC
Relative Strength Index (RSI) 50.71 42.02
Support Level $2.07 $9.36
Resistance Level $3.14 $10.75
Average True Range (ATR) 0.14 0.45
MACD -0.00 -0.07
Stochastic Oscillator 27.72 29.56

Price Performance

Historical Comparison
CCLD
ICCC

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: